Policy Makers

This advocacy brochure shows how one million lives can be saved by the end of 2015 by preventing and treating tuberculosis among people living with HIV.

WHO and The Union have developed a Collaborative Framework for Care and Control of Tuberculosis and Diabetes, which presents recommendations based on evidence from systematic reviews and a series of expert consultations. It outlines essential steps for coordinated action in three areas: (1) establishment of mechanisms for collaboration between national TB programmes and suitable counterparts responsible for care and control of diabetes; (2) improved detection and management of TB in patients with diabetes; (3) improved detection and management of diabetes in patients with TB.

This webpage provides summary information on Connecticut's quarantine laws.

This guide specifically addresses issues such as stigma and work discrimination, and also provides practical recommendations on how to establish an effective monitoring system.

This report highlights the issues surrounding high prices and poor supply of the drugs needed to treat drug-resistant tuberculosis (DR-TB). The report provides an overview of available drug-resistant TB medicines, including drug sources, quality status, and price.

This fact sheet discusses the deadly duo of TB-HIV, and how members of both TB and HIV communities can work together.

This toolkit was developed to help National TB Program managers and others involved in the management of TB programs develop new National Strategic Plans or improve existing ones.

This infographic depicts the global epidemiology of TB.

This document provides a generic framework for implementing TB diagnostics. Topics covered include managerial, technical, and operational processes required for developing and implementing a national strategy for TB laboratories.

The objectives of this document are to describe the best practices in engaging different health providers and partners in the management of drug-resistant TB patients and to describe the necessary components in planning and implementing a public-private mix for the management of drug-resistant TB.